Thus, these findings suggested that MARCKSL1 influences the progression of MVI and cancer malignancy through PTN-related signalling, which is supported by immunohistochemistry results from the Human Protein Atlas showing greater expression of MARCKSL1 in cancerous tissues than in adjacent noncancerous tissues (Figure 9H). Here, MARCKSL1 is linked to cancer.